- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Drug alert: CDSCO flags 62 drug samples
Overview
In its latest drug alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 62 medicine batches for failing to qualify for a random drug sample test for the month of September.
These drug samples which are declared not of standard quality include Moxiflox-D Eye Drops, Viscoril AP, Caffeine Citrate Injection USP 60mg/3ml, Pyrazinamide-500 manufactured by Jackson Laboratories, Omeprazole Capsules IP 20 mg manufactured by Hindustan Antibiotics, Ascorbic Acid Tablets I.P. 500 mg. manufactured by ANG Lifesciences, Tobramycin Ophthalmic Solution USP 0.3% w/v manufactured by Zee Laboratories.
For more details, check out the link given below:
CDSCO Drug Alert: 62 Drug Samples Including Mankind Pharma's Rabekind 20 Flagged